Mr. Traynor previously spent 10 years at Genzyme Corporation, most recently serving as senior vice president of business unit finance. At ConforMIS he will be responsible for SEC filings, controllership functions and financial planning and forecasting for Genzyme’s eight global business units.
More Articles on Orthopedic Device Companies:
15 Device Company Financial Reports
Tornier 3Q Sales Flat at $58M
DePuy Launches New Trumatch Pin for Orthopedic Implants
ConforMIS Appoints Peter Traynor CFO
Orthopedic device company ConforMIS has appointed Peter Traynor CFO.
